Radiopharm Theranostics Limited (ASX:RAD)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
May 23, 2025, 4:10 PM AEST
Radiopharm Theranostics Revenue
Radiopharm Theranostics had revenue of 2.44M AUD in the half year ending December 31, 2024, a decrease of -42.81%. This brings the company's revenue in the last twelve months to 330.63K, down -94.50% year-over-year. In the fiscal year ending June 30, 2024, Radiopharm Theranostics had annual revenue of 1.96M, down -68.46%.
Revenue (ttm)
330.63K
Revenue Growth
-94.50%
P/S Ratio
148.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
49.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1.96M | -4.25M | -68.46% |
| Jun 30, 2023 | 6.21M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRadiopharm Theranostics News
- 2 months ago - Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting - Seeking Alpha
- 2 months ago - This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga